Global Immune Repertoire Sequencing Market
Global Immune Repertoire Sequencing Market was valued at USD 116.2 million in 2020 and is expected to reach 180 million by 2030 at a CAGR 7.6% 2020-2030.
The Immune Repertoire Sequencing is defined as a rate and sensitive platform technology with less fitfall. It is used in biomarker discovery to improve the success rate & cost effectiveness of rational drug development. Also, they are used in the variety of applications such as cancer immunotherapy, asthma & allergies, infectious diseases research and many more.
Market Drivers
The increase in research and development and demand for genomic & repertoire sequencing-based research is anticipated to boost the growth of global immune repertoire sequencing market growth over the forecast period. Also, the increase in launches of novel products by key players is expected to drive the market growth. For instance, in 2016, ArcherDX, Inc. had expanded its product portfolio with the launch of its new Archer Immunoverse immune repertoire sequencing assays at the American Society of Hematology.
Furthermore, the increase in demand for personalized medicine will positively influence the growth of the global immune repertoire sequencing market. Moreover, growing the role of next-generation immune repertoire sequencing for personalized immune modulation is expected to support the global immune repertoire sequencing market growth.
Market Restraints
Various challenging factors in global immune repertoire sequencing market include distinguishing biological variations from the errors & the bias introduced in different steps. Conventional & novel bioinformatics techniques like Haystack Heuristic, high throughput screening, and others are not up to the mark due to unsatisfactory scalability & sensitivity as well as limitation in providing sufficient & accurate data which are expected to hamper the global immune repertoire sequencing market growth.
Market Segmentation
The Global Immune Repertoire Sequencing Market is segmented into product type such as assay kits (TCR kits, and BCR Kits), and Instrument (NGS, and PCR), by application such as Biomarker Discovery, Cancer Immunotherapy, Autoimmune Diseases, Vaccine Development and Efficacy, Transplant Rejection &Tolerance, Infectious Diseases and Other. Further, market is segmented into end users such as Biotechnology and Pharmaceuticals Companies, Diagnostics Labs, Academic and Research Institutes and Others.
Regional Analysis
The Global Immune Repertoire Sequencing Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The North America region is expected to held a dominant position in the overall immune repertoire sequencing market over the forecast period, due to the high presence of key industry players in this region. Further, Europe region is expected to gain momentum over the forecast period, due to the increase in funding by the government bodies to support international innovative projects & marketable innovative products, processes, and services, in order to cater unmet medical need.
Market Key Players
Various key players are listed in this report such as Thermo Fisher Scientific, Inc., ArcherDX, Inc., Illumina Inc., Roche Holding AG, CD Genomics, Atreca, Inc., Oxford Nanopore Technologies, Ltd., Qiagen N.V., Agilent Technologies, Inc., Takara Bio, Inc., etc.
Market Taxonomy
By Product Type
By Application
By End User
By Region
Key Questions Addressed by the Report
Global Immune Repertoire Sequencing Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Immune Repertoire Sequencing Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Immune Repertoire Sequencing Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Immune Repertoire Sequencing Market Share Analysis, By Product Type
5.3 Global Immune Repertoire Sequencing Market Size and Forecast, By Product Type
5.3.1 Assay Kits
5.3.1.1. TCR kits
5.3.1.2. BCR Kits
5.3.2. Instrument
5.3.2.1. NGS
5.3.2.2. PCR
6 Global Immune Repertoire Sequencing Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Immune Repertoire Sequencing Market Share Analysis, By Application
6.3 Global Immune Repertoire Sequencing Market Size and Forecast, By Application
6.3.1 Biomarker Discovery
6.3.2 Cancer Immunotherapy
6.3.3 Autoimmune Diseases
6.3.4 Vaccine Development and Efficacy
6.3.5. Transplant Rejection &Tolerance
6.3.6. Infectious Diseases
6.3.7. Other
7 Global Immune Repertoire Sequencing Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Immune Repertoire Sequencing Market Share Analysis, By End User
7.3 Global Immune Repertoire Sequencing Market Size and Forecast, By End User
7.3. 1 Biotechnology and Pharmaceuticals Companies
7.3.2. Diagnostics Labs
7.3.3. Academic and Research Institutes
7.3.4. Others
8 Global Immune Repertoire Sequencing Market, By Region
8.1 Global Immune Repertoire Sequencing Market Share Analysis, By Region
8.2 Global Immune Repertoire Sequencing Market Share Analysis, By Region
8.3 Global Immune Repertoire Sequencing Market Size and Forecast, By Region
9 North America Immune Repertoire Sequencing Market Analysis and Forecast (2020-2030)
9.1 Introduction
9.2 North America Immune Repertoire Sequencing Market Share Analysis, By Product Type
9.3 North America Immune Repertoire Sequencing Market Size and Forecast, By Application
9.4 North America Immune Repertoire Sequencing Market Size and Forecast, By End User
9.5 North America Immune Repertoire Sequencing Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Immune Repertoire Sequencing Market Analysis and Forecast (2020-2030)
10.1 Introduction
10.2 Europe Immune Repertoire Sequencing Market Share Analysis, By Product Type
10.3 Europe Immune Repertoire Sequencing Market Size and Forecast, By Application
10.4 Europe Immune Repertoire Sequencing Market Size and Forecast, By End User
10.5 Europe Immune Repertoire Sequencing Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11 Asia Pacific Immune Repertoire Sequencing Market Analysis and Forecast (2020-2030)
11.1 Introduction
11.2 Asia Pacific Immune Repertoire Sequencing Market Share Analysis, By Product Type
11.3 Asia Pacific Immune Repertoire Sequencing Market Size and Forecast, By Application
11.4 Asia Pacific Immune Repertoire Sequencing Market Size and Forecast, By End User
11.5 Asia Pacific Immune Repertoire Sequencing Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12 Latin America Immune Repertoire Sequencing Market Analysis and Forecast (2020-2030)
12.1 Introduction
12.2 Latin America Immune Repertoire Sequencing Market Share Analysis, By Product Type
12.3 Latin America Immune Repertoire Sequencing Market Size and Forecast, By Application
12.4 Latin America Immune Repertoire Sequencing Market Size and Forecast, By End User
12.5 Latin America Immune Repertoire Sequencing Market Size and Forecast, Country
13 Middle East Immune Repertoire Sequencing Market Analysis and Forecast (2020-2030)
13.1 Introduction
13.2 Middle East Immune Repertoire Sequencing Market Share Analysis, By Product Type
13.3 Middle East Immune Repertoire Sequencing Market Size and Forecast, By Application
13.4 Middle East Immune Repertoire Sequencing Market Size and Forecast, By End User
13.5 Middle East Immune Repertoire Sequencing Market Size and Forecast, By Country
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Thermo Fisher Scientific, Inc
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. ArcherDX, Inc
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Illumina Inc
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Roche Holding AG
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 CD Genomics
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Atreca, Inc
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Oxford Nanopore Technologies, Ltd
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Qiagen N.V.
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Agilent Technologies, Inc
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Takara Bio, Inc
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
